In patients with PTC, high levels of LASP1 were associated with a lower overall survival (Fig. 4E), and correlated with the TNM stage and lymph node metastasis (Table 1). This evidence concerns the gene LASP1 and metastatic malignant neoplasm in the lymph nodes.